Department of Physiology and Pharmacology, School of Medicine, Ningbo University, 818 Fenghua Rd, Ningbo, Zhejiang, 315211, People's Republic of China. shenhaowei@nbu.edu.cn.
2 papers in the library · 14 citations · publishing 2023
A substituted phenethylamine psychedelic, 25C-NBOMe, increases the ratio of excitation to inhibition in the orbitofrontal cortex by enhancing glutamatergic transmission and reducing GABAergic transmission via the 5-HT2A receptor. It also boosts the intrinsic excitability of pyramidal neurons, but not fast-spiking interneurons, through mechanisms involving G protein-gated inwardly rectifying potassium channels and protein kinase C. These effects collectively shift local excitation/inhibition balance toward excitation, which may underlie the therapeutic potential of psychedelics for disorders like obsessive-compulsive disorder.
The substituted phenethylamine psychedelic 25C-NBOMe, at a dose of 0.1 mg/kg that disrupts sensorimotor gating, selectively potentiates high frequency oscillation (HFO, 120-150 Hz) power in the orbitofrontal cortex (OFC) of male Sprague-Dawley rats, peaking 20-30 minutes after treatment. It strengthens HFO coherence within the intra-prefrontal network but not the hippocampal-prefrontal network. Potentiated OFC HFO strongly correlates with strengthened inter-prefrontal HFO coherence. Pre-treatment with the serotonin 2A receptor antagonist MDL100,907 prevents these alterations. The findings indicate that OFC HFO is particularly susceptible to this psychedelic and may drive drug-induced rhythmic coherence within prefrontal regions, suggesting altered HFO could serve as a biological marker of psychedelic effects.